ACIP Recommendations: Human Papillomavirus (HPV) Vaccine

Published in Morbidity and Mortality Weekly Report (MMWR)

The Advisory Committee on Immunization Practices (ACIP) provides advice and guidance to the Director of the CDC regarding use of vaccines and related agents for control of vaccine-preventable diseases in the civilian population of the United States. Recommendations made by the ACIP are reviewed by the CDC Director and, if adopted, are published as official CDC/HHS recommendations in the Morbidity and Mortality Weekly Report (MMWR).

CURRENT HPV Vaccine Recommendations

• MMWR, August 16, 2019, Vol 68(32);698-702
  Human Papillomavirus Vaccination for Adults: Updated Recommendations of the Advisory Committee on Immunization Practices
  Print version
• MMWR, December 16, 2016, Vol 65(49);1405-1408
  Use of a 2-Dose Schedule for Human Papillomavirus Vaccination — Updated Recommendations of the Advisory Committee on Immunization Practices
  Print version
• MMWR, March 27, 2015, Vol 64(11);300-304
  Use of 9-Valent Human Papillomavirus (HPV) Vaccine: Updated HPV Vaccination Recommendations of the Advisory Committee on Immunization Practices
  Print version
• MMWR, August 29, 2014, Vol 63(RR-05);1-30
  Human Papillomavirus Vaccination: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
  Print version
• See also:
  • Additional guidance for providers regarding 9-vHPV vaccine use among persons who previously received 2vHPV or 4vHPV vaccine.
    

ARCHIVED HPV Immunization Publications

For your convenience, these archived publications can be used for historical and research purposes.

• MMWR, December 23, 2011, Vol 60(50);1705-1708
  Recommendations on the Use of Quadrivalent Human Papillomavirus Vaccine in Males — Advisory Committee on Immunization Practices (ACIP), 2011
  Print version
• MMWR, May 28, 2010, Vol 59(20);630-632
  Quadrivalent Human Papillomavirus Vaccine (HPV4, Gardasil) for Use in Males and Guidance from ACIP
  Print version
• MMWR, May 28, 2010, Vol 59(20);626-629
  FDA Licensure of Bivalent Human Papillomavirus Vaccine (HPV2, Cervarix) for Use in Females and Updated HPV Vaccination Recommendations from ACIP
  Print version
• MMWR, March 23, 2007, Vol 56(RR-02);1-24
  Quadrivalent Human Papillomavirus Vaccine: Recommendations of ACIP
  Print version